Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 2, Pages 79–84
http://dx.doi.org/10.1155/2013/368732
Research Article

Association of TAP Gene Polymorphisms and Risk of Cervical Intraepithelial Neoplasia

1Department of General Gynaecology and Gynaecological Oncology, Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
2Center for Medical Statistics, Informatics and Intelligent Systems, Section for Clinical Biometrics, Medical University of Vienna, 1090 Vienna, Austria

Received 5 December 2012; Accepted 2 May 2013

Academic Editor: Sudhir Srivastava

Copyright © 2013 Camilla Natter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. McCredie, K. J. Sharples, C. Paul et al., “Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study,” The Lancet Oncology, vol. 9, no. 5, pp. 425–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. M. Parkin and F. Bray, “Chapter 2: the burden of HPV-related cancers,” Vaccine, vol. 24, no. 3, pp. S11–S25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. H. Schiffman, H. M. Bauer, R. N. Hoover et al., “Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia,” Journal of the National Cancer Institute, vol. 85, no. 12, pp. 958–964, 1993. View at Google Scholar · View at Scopus
  4. E. M. de Villiers, D. Wagner, A. Schneider et al., “Human papillomavirus infections in women with and without abnormal cervical cytology,” The Lancet, vol. 2, no. 8561, pp. 703–705, 1987. View at Google Scholar · View at Scopus
  5. M. H. Schiffman, “New epidemiology of human papillomavirus infection and cervical neoplasia,” Journal of the National Cancer Institute, vol. 87, no. 18, pp. 1345–1347, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Collins, T. P. Rollason, L. S. Young, and C. B. J. Woodman, “Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study,” European Journal of Cancer, vol. 46, no. 2, pp. 405–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Appleby, V. Beral, A. Berrington de González et al., “Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies,” International Journal of Cancer, vol. 118, no. 6, pp. 1481–1495, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. F. V. Cromme, J. Airey, M.-T. Heemels et al., “Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas,” Journal of Experimental Medicine, vol. 179, no. 1, pp. 335–340, 1994. View at Publisher · View at Google Scholar · View at Scopus
  9. M. E. Connor and P. L. Stern, “Loss of MHC class-I expression in cervical carcinomas,” International Journal of Cancer, vol. 46, no. 6, pp. 1029–1034, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Spies, M. Bresnahan, S. Bahram et al., “A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway,” Journal of Immunology, vol. 180, no. 5, pp. 2737–2740, 2008. View at Google Scholar · View at Scopus
  11. R. Abele and R. Tampé, “Function of the transport complex TAP in cellular immune recognition,” Biochimica et Biophysica Acta, vol. 1461, no. 2, pp. 405–419, 1999. View at Google Scholar
  12. D. Parcej and R. Tampé, “ABC proteins in antigen translocation and viral inhibition,” Nature Chemical Biology, vol. 6, no. 8, pp. 572–580, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Cresswell, N. Bangia, T. Dick, and G. Diedrich, “The nature of the MHC class I peptide loading complex,” Immunological Reviews, vol. 172, pp. 21–28, 1999. View at Google Scholar · View at Scopus
  14. R. N. Germain, “MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation,” Cell, vol. 76, no. 2, pp. 287–299, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. M.-T. Heemels and H. Ploegh, “Generation, translocation, and presentation of MHC class I-restricted peptides,” Annual Review of Biochemistry, vol. 64, pp. 463–491, 1995. View at Google Scholar · View at Scopus
  16. P. Thor Straten, A. F. Kirkin, T. Seremet, and J. Zeuthen, “Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines,” International Journal of Cancer, vol. 70, pp. 582–586, 1997. View at Google Scholar
  17. F. V. Cromme, C. J. L. M. Meijer, P. J. F. Snijders et al., “Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions,” British Journal of Cancer, vol. 67, no. 6, pp. 1372–1380, 1993. View at Google Scholar · View at Scopus
  18. V. Cerundolo, J. Alexander, K. Anderson et al., “Presentation of viral antigen controlled by a gene in the major histocompatibility complex,” Nature, vol. 345, no. 6274, pp. 449–452, 1990. View at Publisher · View at Google Scholar · View at Scopus
  19. M. H. Einstein, S. Leanza, L. G. Chiu et al., “Genetic variants in TAP are associated with high-grade cervical neoplasia,” Clinical Cancer Research, vol. 15, no. 3, pp. 1019–1023, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. D. M. Kordi Tamandani, R. C. Sobti, M. Shekari, S. A. Husseini, and V. Suri, “No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population,” Journal of Assisted Reproduction and Genetics, vol. 26, no. 4, pp. 173–178, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. L. Fowler and I. H. Frazer, “Mutations in TAP genes are common in cervical carcinomas,” Gynecologic Oncology, vol. 92, no. 3, pp. 914–921, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. B. S. Gostout, G. A. Poland, E. S. Calhoun et al., “TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk,” Gynecologic Oncology, vol. 88, no. 3, pp. 326–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Grimm, R. Watrowski, K. Baumühlner et al., “Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia,” Gynecologic Oncology, vol. 121, no. 3, pp. 537–541, 2011. View at Publisher · View at Google Scholar · View at Scopus